Skip to content

XGN - EXAGEN INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchX

Exagen Inc

XGN · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

X

XGNExagen Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $12.23
52-wk low: $2.59
Prev close: $7.05
Mkt cap: $180.0M
Beta: 2.03
P/S: 2.5x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$8.6M

BA
Balyasny
Dmitry Balyasny · Q1 2026 13F
$2.4M
position
FE
First Eagle
Q2 2026 13F

Earnings

Reported Aug 4, 2026

Earnings came in 31.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -26.6%
Market cap: $180M

Valuation

P/S2.53
P/B13.07

Quality

Operating margin-8.6%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: XGN
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
Market cap: $179.99M
Beta: 2.03

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

13.1x

Profit margin

-26.6%

Op margin

-8.6%

ROE

-113.8%

$1.4M

position

MW

Marshall Wace

Q2 2026 13F

$1.4M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for XGN

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.13+31.6%

-$0.19 expected

Next report

What the street expects next

-113.8%

ROA-14.9%

Growth

Beta2.03